The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Digital health company 1st Group (1ST) has received commitments to raise $4.5 million through a placement
  • The funds will be used to support 1st Group’s growth strategy including additional sales and marketing capabilities and technology development
  • The placement shares will be issued on or around December 18.
  • 1st group is up 5.48 per cent following news of the placement and shares are trading for 7.7 cents each

Digital health company 1st Group (1ST) has received commitments from institutional, sophisticated and professional investors for a $4.5 million placement.

The placement will issue 69,230,769 fully paid ordinary shares at an issue price of $0.065 per share; an 11 per cent discount to the last price before the trading halt.

Funds raised under the placement will be used to support 1st Group’s growth strategy including additional sales and marketing capabilities, technology development, working capital requirement and other general corporate purposes.

“We are delighted with the strong support shown by existing and new investors for 1st Group. This raise was initiated by institutional investor interest and reflects the confidence in our growth strategy and market opportunities,” CEO Klaus Bartosch said.

1st Group is a digital health company with integrated platforms that provide an easy way for health professionals and patients to book and schedule appointments.

The placement shares will be issued on or around December 18.

1st group is up 5.48 per cent following news of the placement and shares are trading for 7.7 cents each at 1:44 pm AEDT.

1ST by the numbers
More From The Market Online
Knee arthritis concept

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Paradigm has confirmed it will use a twice weekly dosage of 2mg/kg injectable pentosan polysulfate sodium…
Tooth and dental instruments on blue background.

Pacific Smiles receives new takeover offer, boosting valuation of shares by 50 cents each

Pacific Smiles Group Ltd has received an off-market takeover offer from Beam Dental Bidco Pty Ltd,…
3D model of prostate cancer cells

Clarity progresses SECuRE trial with positive safety results

Clarity Pharmaceuticals Ltd has reported strong results from Cohort 4 of the SECuRE trial examining a…
Mexican healthcare concept ai gen

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

Dimerix Limited (ASX:DXB) has confirmed it's begun recruiting adolescent kidney disease patients in Mexico, now that…